Vaishali Pharma [VAISHALI] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Vaishali Pharma

NSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vaishali Pharma wins in 4 metrics, Divi's Laboratories wins in 14 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVaishali PharmaDivi's LaboratoriesBetter
P/E Ratio (TTM)187.3367.57Divi's Laboratories
Price-to-Book Ratio2.3410.40Vaishali Pharma
Debt-to-Equity Ratio18.980.03Divi's Laboratories
PEG RatioN/A2.55N/A
EV/EBITDA-181.0749.66Vaishali Pharma
Profit Margin (TTM)0.38%23.89%Divi's Laboratories
Operating Margin (TTM)5.16%25.60%Divi's Laboratories
EBITDA Margin (TTM)5.16%25.60%Divi's Laboratories
Return on Equity1.26%14.64%Divi's Laboratories
Return on Assets (TTM)0.74%12.94%Divi's Laboratories
Free Cash Flow (TTM)$-183.43M$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return-46.57%-5.14%Divi's Laboratories
Price-to-Sales Ratio (TTM)1.4016.13Vaishali Pharma
Enterprise Value$1.54B$1,522.01BDivi's Laboratories
EV/Revenue Ratio1.4715.77Vaishali Pharma
Gross Profit Margin (TTM)1.47%60.33%Divi's Laboratories
Revenue per Share (TTM)$8$363Divi's Laboratories
Earnings per Share (Diluted)$0.06$86.82Divi's Laboratories
Beta (Stock Volatility)0.270.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Vaishali Pharma vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Vaishali Pharma
Divi's Laboratories
Vaishali Pharma Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vaishali Pharma1.16%-1.13%-7.94%-3.73%-7.56%-36.20%
Divi's Laboratories-0.67%2.26%-3.33%-15.42%10.79%-4.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vaishali Pharma-46.57%15.90%204.01%168.79%168.79%168.79%
Divi's Laboratories-5.14%63.08%80.80%444.71%1,530.25%8,023.95%

News Based Sentiment: Vaishali Pharma vs Divi's Laboratories

Vaishali Pharma

News based Sentiment: MIXED

September presented a mixed bag for Vaishali Pharma, with revenue growth failing to translate into profit, coupled with insider trading activity and a high valuation. While there were some positive signals like the bulk purchase of shares, the overall picture remains complex and requires careful monitoring.

View Vaishali Pharma News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

Divi's Laboratories reported strong Q3 results, but also faces mixed analyst opinions, recent underperformance, and a shift in technical trends. The company is also taking on new debt, indicating a strategic change. These factors create a complex investment narrative.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Vaishali Pharma vs Divi's Laboratories

MetricVAISHALIDIVISLAB
Market Information
Market Cap i₹1.51B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i270,987455,187
90 Day Avg. Volume i348,974395,686
Last Close₹11.37₹5,826.50
52 Week Range₹10.30 - ₹24.91₹4,955.00 - ₹7,071.50
% from 52W High-54.36%-17.61%
All-Time High₹24.91 (Oct 14, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-54.36%-17.61%
Growth Metrics
Quarterly Revenue Growth0.31%0.14%
Quarterly Earnings Growth-0.25%0.27%
Financial Health
Profit Margin (TTM) i0.00%0.24%
Operating Margin (TTM) i0.05%0.26%
Return on Equity (TTM) i0.01%0.15%
Debt to Equity (MRQ) i18.980.03
Cash & Liquidity
Book Value per Share (MRQ)₹4.79₹563.87
Cash per Share (MRQ)₹0.14₹132.86
Operating Cash Flow (TTM) i₹-326,443,000₹19.67B
Levered Free Cash Flow (TTM) i₹8.17M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Vaishali Pharma vs Divi's Laboratories

MetricVAISHALIDIVISLAB
Price Ratios
P/E Ratio (TTM) i187.3367.57
Forward P/E iN/A104.19
PEG Ratio iN/A2.55
Price to Sales (TTM) i1.4016.13
Price to Book (MRQ) i2.3410.40
Market Capitalization
Market Capitalization i₹1.51B₹1.61T
Enterprise Value i₹1.54B₹1.52T
Enterprise Value Metrics
Enterprise to Revenue i1.4715.77
Enterprise to EBITDA i-181.0749.66
Risk & Other Metrics
Beta i0.270.18
Book Value per Share (MRQ) i₹4.79₹563.87

Financial Statements Comparison: Vaishali Pharma vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VAISHALIDIVISLAB
Revenue/Sales i₹311.02M₹24.10B
Cost of Goods Sold i₹306.45M₹9.56B
Gross Profit i₹4.58M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹1.33M₹6.17B
EBITDA i₹9.89M₹8.48B
Pre-Tax Income i₹-56.02M₹7.33B
Income Tax i₹-13.10M₹1.88B
Net Income (Profit) i₹-42.93M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VAISHALIDIVISLAB
Cash & Equivalents i₹17.11M₹4.15B
Total Current Assets i₹1.04B₹100.81B
Total Current Liabilities i₹400.53M₹14.52B
Long-Term Debt i₹46.19M₹20.00M
Total Shareholders Equity i₹649.16M₹149.69B
Retained Earnings i₹157.29M₹134.00B
Property, Plant & Equipment i₹0₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VAISHALIDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVAISHALIDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i270,987455,187
Average Daily Volume (90 Day) i348,974395,686
Shares Outstanding i130.46M265.47M
Float Shares i74.91M120.77M
% Held by Insiders iN/A0.52%
% Held by Institutions iN/A0.29%

Dividend Analysis & Yield Comparison: Vaishali Pharma vs Divi's Laboratories

MetricVAISHALIDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025